Members directory | Become a member | My DCVMN

Contact us

News

June 4, 2025

Regulatory Approval for Innovax’s HPV vaccine, Cecolin®9 from NMPA

Members' achievements Vaccines & immunization

May 22, 2025

DCVMN CEO at the 2nd edition of the Vaccine World Forum

CEO DCVMN Advocacy WeConnectToProtect

May 10, 2025

DCVMN MSG and QbD Working Groups Meet in Geneva

DCVMN Working Groups Workforce Training

May 8, 2025

DCVMN at the ICMR-CEPI Collaborative Workshop on H5N1 Vaccine Readiness

developingcountries Pandemic Preparedness Vaccines & immunization

April 24, 2025

DCVMN Board at the World Vaccine Congress in Washington D.C.

DCVMN Advocacy DCVMN Board WeConnectToProtect

April 10, 2025

Driving Predictable and Sustainable Vaccine Demand: DCVMN at the RVMC Meeting in Abu Dhabi

CEO DCVMN Advocacy RVMC Vaccine Demand

April 9, 2025

Strengthening Local Vaccine Manufacturing: DCVMN at the 3rd World Local Production Forum in Abu Dhabi

CEO DCVMN Advocacy WeConnectToProtect WHO

March 31, 2025

DCVMN Strengthens Strategic Dialogue with Global Health Institutions in China

DCVMN Advocacy WeConnectToProtect

March 28, 2025

DCVMN CEO Meets with Chinese Member Companies

CEO Members WeConnectToProtect

March 22, 2025

DCVMN Strengthens Global Vaccine Collaboration at the Vaccine Innovation Forum 2025

CEO China DCVMN Advocacy Vaccine Equity

January 23, 2025

WHO Prequalification for SPbSRIVS and Instituto Mechnikov’s FLU-M Influenza Vaccine

Members' achievements Vaccines & immunization WHO

January 19, 2025

Pharmacovigilance Working Group’s New Publication: Enhancing Vaccine Safety Surveillance in LMICs

DCVMN achievements DCVMN Working Groups Pharmacovigilance Publication

Our sponsors

Our sponsors

Our sponsors

Our sponsors